AstraZeneca will no longer invest 450 million pounds ($558.3 million) at its vaccine manufacturing plant in northern England, ...

AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Liverpool, blaming a reduction in government support. The pharmaceutical giant has announced its decision ...

AstraZeneca has cancelled a £450m investment in a manufacturing plant, saying Labour have failed to match the previous ...

AstraZeneca has dropped its plans to £450m at its vaccine manufacturing plant in Speke, Merseyside, blaming a reduction in ...

The pharmaceutical giant claimed the Labour Government failed to match its predecessor’s offer of help for the Merseyside ...

AstraZeneca has axed plans to build a £450million vaccine manufacturing plant because of a lack of Government support in the ...

AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday.

AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding ...

AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...

The pharma giant blamed the Labour government reducing support as it dramatically torpedoed the development on Merseyside.

Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous government’s proposal' ...

The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in ...